medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2021, Number 4

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2021; 37 (4)

Towards health equity in hemophilia

Castillo GDC

Language: Spanish
References: 9
Page: 1-4
PDF size: 153.04 Kb.


Text Extraction

No abstract.


REFERENCES

  1. World Health Organization [Internet]. Health systems topics. Equidad. 2015 [acceso 29/04/2021].Disponible en: https://www.who.int/healthsystems/topics/equity/en/

  2. Skinner MW, Nugent D, Wilton P, O'Mahony B, Dolan G, O'Hara J, et al. Achieving the unimaginable: Health equity in haemophilia. Haemophilia.2020;26(1):17-24. DOI: https://10.1111/hae.13862

  3. Mancuso ME, Mahlangu JN, Pipe SW. The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing. Lancet.2021 Feb;397(10274):630-40. DOI: https://10.1016/S0140-6736(20)32722-7

  4. Valentino LA, Khair K. Prophylaxis for hemophilia A without inhibitors: treatment options and considerations. Expert Rev Hematol. 2020Jul;13(7):731-43. DOI: https://10.1080/17474086.2020.1775576

  5. Pierce GF, Kaczmarek R, Noone D, O'Mahony B, Page D, Skinner MW. Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor? Haemophilia. 2020 Nov;26(6):931-3. DOI: https://10.1111/hae.14131

  6. Castillo González D. Red nacional de hemofilia: pasos hacia un gran objetivo. Rev Cubana Hematol Inmunol Hemoter [Internet].2019 [acceso 29/04/2021]; 35(2):[aprox. 0 p.]. Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/1069

  7. Baganet Cobas A, Sagarra Verans M, Castillo González D, Fundora Sarraff T, Lavaut Sánchez K, Padrón Mirabal Y.et al. Radiosinoviortesis con suspensión de fosfato crómico [32P] en pacientes hemofílicos. Rev Cubana Ortop Traumatolr [Internet]. 2014 [acceso 05/06/2021];28(1):2-13.Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-215X2014000100002&lng=es.

  8. García Hadfeg O, Suárez Beyries LC, Alí Pérez N, Rivaflecha Torres Y, Vaillant Beltran I, Hemofilia A y terapia regenerativa con plaquetas. MEDISAN. [Internet]. 2014 [acceso 05/06/2021];18(10):1436-40.Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192014001000014&lng=es.

  9. Jackson S, Santoro C, Gue D, Ferretti A, Gaglioti D, Squire S, et al. Clinical practice of personalized prophylaxis in hemophilia: Illustrations of experiences and benefits from two continents. Clin Case Rep. 2019 Feb;7(4):689-94. DOI: https://10.1002/ccr3.2021




2020     |     www.medigraphic.com